Coronary heart disease (CHD) remains a leading cause of death and disability worldwide, despite significant advances in both prevention and treatment. Approximately 32% of all deaths are attributable to cardiovascular disease and the bulk of these are due to CHD (7). Accordingly, effective prevention of CHD would have profound implications for global health. Epidemiological, genetic, pharmacological, and animal studies implicate elevated plasma levels of low density lipoprotein-cholesterol (LDL-C) as the primary cause of CHD, and clinical trials have consistently shown that reduction of plasma LDLC levels is an effective strategy to prevent the disease. Consequently, LDL-lowering now constitutes the cornerstone of CHD prevention programs. Although several effective LDL-lowering agents are available, new therapeutic options are needed since >25% of patients fail to reach treatment goals (8). A major objective of this proposed project is to identify new therapeutic targets for LDL-lowering.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Smagris, Eriks; BasuRay, Soumik; Li, John et al. (2015) Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61:108-18
Ulrich, Victoria; Konaniah, Eddy S; Herz, Joachim et al. (2014) Genetic variants of ApoE and ApoER2 differentially modulate endothelial function. Proc Natl Acad Sci U S A 111:13493-8
Ulrich, Victoria; Konaniah, Eddy S; Lee, Wan-Ru et al. (2014) Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice. J Am Heart Assoc 3:e001369
Gusarova, Viktoria; Alexa, Corey A; Na, Erqian et al. (2014) ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell 159:691-6
Reboldi, Andrea; Dang, Eric V; McDonald, Jeffrey G et al. (2014) Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345:679-84
Xu, Min; Nagati, Jason S; Xie, Jian et al. (2014) An acetate switch regulates stress erythropoiesis. Nat Med 20:1018-26
Kozlitina, Julia; Smagris, Eriks; Stender, Stefan et al. (2014) Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 46:352-6
Das, Akash; Brown, Michael S; Anderson, Donald D et al. (2014) Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis. Elife 3:
Maetzel, Dorothea; Sarkar, Sovan; Wang, Haoyi et al. (2014) Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells. Stem Cell Reports 2:866-80
Lane-Donovan, Courtney; Philips, Gary T; Herz, Joachim (2014) More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration. Neuron 83:771-87

Showing the most recent 10 out of 670 publications